These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2024972)

  • 1. Penetration of ofloxacin into human lung tissue following a single oral dose of 200 milligrams.
    Serour F; Dan M; Gorea A; Yellin A; Lieberman Y; Berger SA
    Antimicrob Agents Chemother; 1991 Feb; 35(2):380-1. PubMed ID: 2024972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The penetration of ofloxacin into lung tissue.
    Wijnands WJ; Vree TB; Baars AM; Hafkenscheid JC; Kohler BE; van Herwaarden CL
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():85-9. PubMed ID: 3182467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
    Mertes PM; Jehl F; Burtin P; Dopff C; Pinelli G; Villemot JP; Monteil H; Dureux JB
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2493-6. PubMed ID: 1489193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ofloxacin concentration in human prostatic tissue after 3 days of administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jan; 35(1):187-90. PubMed ID: 2729016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin.
    Donnenfeld ED; Perry HD; Snyder RW; Moadel R; Elsky M; Jones H
    Arch Ophthalmol; 1997 Feb; 115(2):173-6. PubMed ID: 9046250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ofloxacin penetration into the eye after intravenous and topical administration.
    Fiscella RG; Shapiro MJ; Solomon MJ; Kurtz RM; Mui S; Labib S
    Retina; 1997; 17(6):535-9. PubMed ID: 9428017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin concentrations in tissues involved in respiratory tract infections.
    Perea EJ
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():55-60. PubMed ID: 2286591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of ofloxacin in serum and tonsils.
    Van Landuyt HW; Gordts B; D'Hondt G
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():81-3. PubMed ID: 3182466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin concentrations in serum, saliva and pleural effusion of patients with pulmonary tuberculosis and lung cancer.
    Miya T; Hamakubo S; Goya T; Hanaoka T; Hosaka K
    Jpn J Antibiot; 1995 Jul; 48(7):960-4. PubMed ID: 7563589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and prostatic tissue concentrations of ofloxacin.
    Fujita K; Munakata A
    Clin Ther; 1988; 10 Spec No():32-5. PubMed ID: 3233627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
    Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Retina; 1998; 18(6):521-5. PubMed ID: 9869460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis.
    Bielecka-Grzela S; Klimowicz A
    Pol J Pharmacol; 2003; 55(4):613-8. PubMed ID: 14581720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous humor penetration of ofloxacin given by various routes.
    von Gunten S; Lew D; Paccolat F; Vaudaux P; Brazitikos PD; Leuenberger PM
    Am J Ophthalmol; 1994 Jan; 117(1):87-9. PubMed ID: 8291598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and serum concentrations of ofloxacin in the ear region following a single daily oral dose of 400 mg.
    Tolsdorff P
    Infection; 1993; 21(1):63-5. PubMed ID: 8449586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
    Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Beauchant M
    Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections.
    Kuck EM; Bouter KP; Hoekstra JB; Conemans JM; Diepersloot RJ
    Foot Ankle Int; 1998 Jan; 19(1):38-40. PubMed ID: 9462911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis.
    Hwang SM; Kim DD; Chung SJ; Shim CK
    J Control Release; 2008 Jul; 129(2):100-6. PubMed ID: 18538437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.